Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Zwaenepoel

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Seminars in Arthritis and Rheumatism|July 3, 2016
SAPHO: Treatment options including bisphosphonatesTom Zwaenepoel, Kurt de Vlam
RMD Open|August 8, 2024
Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trialDelphine Bertrand, Johan Joly, Barbara Neerinckx, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Seminars in Arthritis and Rheumatism|July 3, 2016
SAPHO: Treatment options including bisphosphonatesTom Zwaenepoel, Kurt de Vlam
RMD Open|August 8, 2024
Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trialDelphine Bertrand, Johan Joly, Barbara Neerinckx, et al.
Pageof 1